News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Henig Noreen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Henig Noreen (Chief Medical Officer) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 220,000 options to buy
@ $6.84, valued at
$1.5M
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Henig Noreen (Chief Medical Officer) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 180,000 options to buy
@ $14.55, valued at
$2.6M
|
|
| 06/16/2021 |
4
| Henig Noreen (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $26.09, valued at
$391.4k
|
|
| 02/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
3
| Henig Noreen (Director) has filed a Form 3 on Avidity Biosciences, Inc. |
| 05/04/2020 |
4
| Henig Noreen (Chief Medical Officer) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 300,000 options to buy
@ $4.56, valued at
$1.4M
|
|
| 05/04/2020 |
3
| Henig Noreen (Chief Medical Officer) has filed a Form 3 on Kezar Life Sciences, Inc. |
|
|